Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2005-10-14
2010-02-09
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C530S395000
Reexamination Certificate
active
07658919
ABSTRACT:
The present invention provides compositions and methods for treating or preventing bacterial infections. Also provide by the invention are genetically modified cell expressing Lewisbcarbohydrate epitope.
REFERENCES:
patent: 5225538 (1993-07-01), Capon et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5516964 (1996-05-01), Umansky et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 7355017 (2008-04-01), Lofling et al.
patent: 2003/0073822 (2003-04-01), Lofling et al.
patent: WO 03/010201 (2003-02-01), None
patent: WO 03/089450 (2003-10-01), None
de Vries et al. (Glycobiol., 11:119R-128R, 2001).
Shiraishi et al. (J. Biol. Chem., 276:3498-3507, 2001).
Lofling et al. Abstract No. 627.4, FASEB J., vol. 17, No. 4-5, Mar. 2003.
Lofling et al. Glycobiol., 12:173-182, 2002.
Amado et al., “A Family of Human β3-Galactosyltransferases”,J. Biol. Chem., 273(21):12770-12778 (1998).
Amano et al., “Expression of the H Type 1 Blood Group Antigen during Enterocytic Differentiation of Caco-2 Cells”,J. Biol. Chem., 274(30):21209-21216 (1999).
Appelmelk et al., “Cutting Edge: Carbohydrate Profiling Identifies New Pathogens That Interact with Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin on Dendritic Cells”,J. Immunol., 170:1635-1639 (2003).
Bergman et al.,Helicobacter pyloriModulates the T Helper Cell 1/T Helper Cell 2 Balance through Phase-variable Interaction between Lipopolysaccharide and DC-SIGN,J. Exp. Med., 200(8):979-990 (2004).
Cole et al., “Identification, expression analysis, and mapping ofB3galt6, a putative galactosyl transferase gene with similarity toDrosophila brainiac”, Mamm. Genome, 12:177-179 (2001).
Falk et al., “Expression of a human α-1,3/4-fucosyltransferase in the pit cell lineage of FVB/N mouse stomach results in production of Leb-containing glycoconjugates: A potential transgenic mouse model for studyingHelicobacter pyloriinfection”Proc. Natl. Acad. Sci. U.S.A., 92:1515-1519 (1995).
GenBank Accession No. AAH12725, Jul. 15, 2006, 3 pages.
GenBank Accession No. AAH26238, Jul. 15, 2006, 3 pages.
GenBank Accession No. AJ417832, Oct. 21, 2008, 4 pages.
GenBank Accession No. BAA13941, Oct. 5, 2006, 2 pages.
GenBank Accession No. BAA13942, Oct. 5, 2006, 2 pages.
GenBank Accession No. BC012725, Jul. 15, 2006, 4 pages.
GenBank Accession No. BC026238, Jul. 15, 2006, 3 pages.
GenBank Accession No. CAD10625, Oct. 21, 2008, 3 pages.
GenBank Accession No. D89324, Oct. 5, 2006, 3 pages.
GenBank Accession No. D89325, Oct. 5, 2006, 3 pages.
GenBank Accession No. NM—000149, Mar. 22, 2009, 6 pages.
GenBank Accession No. NM—000511, Apr. 5, 2009, 6 pages.
GenBank Accession No. NM—009151, Apr. 5, 2009, 5 pages.
GenBank Accession No. NM—016888, Feb. 1, 2009, 5 pages.
GenBank Accession No. NM—053288, Jan. 13, 2008, 4 pages.
GenBank Accession No. NM—144677, Feb. 1, 2009, 7 pages.
GenBank Accession No. NM—145650, Dec. 21, 2008, 5 pages.
GenBank Accession No. NM—198955, Feb. 1, 2009, 7 pages.
GenBank Accession No. NP—000140, Mar. 22, 2009, 4 pages.
GenBank Accession No. NP—000502, Apr. 5, 2009, 4 pages.
GenBank Accession No. NP—058584, Feb. 1, 2009, 3 pages.
GenBank Accession No. NP—653278, Feb. 1, 2009, 4 pages.
GenBank Accession No. NP—663625, Dec. 21, 2008, 3 pages.
GenBank Accession No. NP—945193, Feb. 1, 2009, 4 pages.
GenBank Accession No. NP—000598, Apr. 12, 2009, 4 pages.
GenBank Accession No. NP—0033177, Apr. 5, 2009, 4 pages.
GenBank Accession No. NP—044570, Apr. 15, 2009, 3 pages.
GenBank Accession No. XM—006867, Aug. 1, 2002, 3 pages.
GenBank Accession No. XM—140694, Oct. 8, 2002, 2 pages.
GenBank Accession No. XP—006867, Aug. 1, 2002, 2 pages.
GenBank Accession No. XP—140694, Oct. 8, 2002, 2 pages.
Gerhard et al., “Clinical relevance of theHelicobacter pylorigene for blood-group antigen-binding adhesion”,Proc. Natl. Acad. Sci. U.S.A., 96(22):12778-12783 (1999).
Guruge et al., “Epithelial attachment alters the outcome ofHelicobacter pyloriinfection”,Proc. Natl. Acad. Sci. U.S.A., 95:3925-3930 (1998).
Holgersson et al., “Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity”,Glycobiol., Abstract #133, 15(11):1219 (2005).
Ilver et al., “Helicobacter pyloriAdhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging”,Science, 279:373-377 (1998).
Isshiki et al., “Cloning, Expression, and Characterization of a Novel UDP-galactose:β-N-Acetylglucosamine β1,3-Galactosyltransferase (β3Gal-T5) Responsible for Synthesis of Type 1 Chain in Colorectal and Pancreatic Epithelia and Tumor Cells Derived Therefrom”,J. Biol. Chem., 274(18):12499-12507 (1999).
Iwai et al., “Molecular Cloning and Characterization of a Novel UDP-GlcNAc:GalNAc-peptide β1,3-N-Acetylglucosaminyltransferase (β3Gn-T6), an Enzyme Synthesizing the Core 3 Structure ofO-Glycans”J. Biol. Chem., 277(15):12802-12809 (2002).
Kelly et al., “Sequence and Expression of a Candidate for the Human Secretor Blood Group α(1,2)Fucosyltransferase Gene (FUT2)”,J. Biol. Chem., 270(9):4640-4649 (1995).
Kolbinger et al., “Cloning of a Human UDP-galactose:2-Acetamido-2-deoxy-D-glucose 3β-Galactosyltransferase Catalyzing the Formation of Type 1 Chains”,J. Biol. Chem., 273(1):433-440 (1998).
Kotani et al., “Knockout of mouse β1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins”,Biochem. J., 357:827-834 (2001).
Kukowska-Latallo et al., “A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4)fucosyltransferase”,Genes Dev., 4:1288-1303 (1990).
Löfling et al., “Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood groupA determinants: core saccharide chain specificity of theSeandHgene encoded α1,2 fucosyltransferases in different host cells”,Glycobiology, 12(3):173-182 (2002).
Mahdavi et al.,Helicobacter pyloriSabA Adhesion in Persistent Infection and Chronic Inflammation,Science, 297:573-578 (2002).
Mare et al., “Suppression of α1,3galactosyltransferase β3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans”,Eur. J. Biochem., 271:186-194 (2004).
Mitoma et al., “Extended core 1 and core 2 branched O-glycans differentially modulate Sialyl Lewis x-type L-selectin ligand activity”,J. Biol. Chem., 278(11):9953-9961 (2003).
Narimatsu et al., “Genetic Evidence for the Lewis Enzyme, Which Synthesizes Type-1 Lewis Antigens in Colon Tissue, and Intracellular Localization of the Enzyme”,Cancer Res., 56:330-338 (1996).
Narimatsu et al., “LewisandSecretorGene Dosages Affect CA 19-9 and DU-PAN-2 Serum Levels in Normal Individuals and Colorectal Cancer Patients”,Cancer Res., 58:512-518 (1998).
Prieto et al., “Expression of Human H-type α1,2-Fucosyltransferase Encoding for Blood Group H(O) Antigen in Chinese Hamster Ovary Cells”,J. Biol. Chem., 272(4):2089-2097 (1997).
Prinz et al., “Key Importance of theHelicobacter pyloriAdherence Factor Blood Group Antigen Binding Adhesin during Chronic Gastric Inflammation”,Cancer Res., 61:1903-1909 (2001).
Rad et al., “TheHelicobacter pyloriBlood Group Antigen-Binding Adhesin Facilitates Bacterial Colonization and Augments a Nonspecific Immune Response”,J. Immunol., 168:3033-3041 (2002).
Takahashi et al., “A Novel In Vitro Infection Model o
Gustafsson Anki
Holgersson Jan
Liu Jining
Lofling Jonas
Elrifi Ivor R.
Gangle Brian J
Kozakiewicz Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Mondesi Robert B
LandOfFree
Compositions and methods for inhibiting H. pylori adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibiting H. pylori adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting H. pylori adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4169385